Related Experiment Videos
High-dose intravenous gammaglobulin for chronic inflammatory demyelinating polyneuropathy
1Div. Neurologica, Ospedale Generale di Bolzano.
Italian Journal of Neurological Sciences
|August 1, 1987
Abstract:
We report our preliminary experience of high-dose intravenous gammaglobulin in patients with chronic inflammatory demyelinating polyneuropathy (CIDP) selected for inefficacy or severe side effects of steroid and immunosuppressive treatment. Our treatment proved safe and effective, reversing the disability of CIDP, the improvement being temporally related to the commencement of intravenous high-dose gammaglobulin. The possible mechanisms of action are discussed.